February 23, 2022 01:14 PM ESTUpdated February 25, 12:39 PM
Pharma
Marketing

Phar­ma sus­tain­abil­i­ty: Am­gen de­buts $750M ‘green bond,’ Mer­ck ini­ti­ates ESG goal re­view

Beth Snyder Bulik

Senior Editor

A pair of en­vi­ron­ment, so­cial and gov­er­nance (ESG) news re­ports this week point out the em­pha­sis phar­ma is putting on sus­tain­abil­i­ty ef­forts thanks to in­creas­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times